Scotiabank Upgrades Sarepta Therapeutics (SRPT) to Sector Outperform, 'Attractive Risk Reward Ahead of Important Catalysts'
Tweet Send to a Friend
(Updated - June 6, 2025 7:07 AM EDT)
Scotiabank analyst Louise Chen upgraded Sarepta Therapeutics (NASDAQ: SRPT) from Sector ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Scotiabank analyst Louise Chen upgraded Sarepta Therapeutics (NASDAQ: SRPT) from Sector ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
